Vildagliptin API
| Name of Product | Vildagliptin API |
|---|---|
| CAS No | 274901‑16‑5 |
| Therapeutic use:- | DPP‑4 inhibitor – type 2 diabetes treatment |
| Grade | IP/IH |
| Form:- | API Powder |
| Status | Commercial |
Product Overview
Vildagliptin is a widely used antidiabetic active pharmaceutical ingredient (API) from the Dipeptidyl Peptidase-4 (DPP-4) inhibitor class.
Vildagliptin treats patients with Type 2 Diabetes Mellitus (T2DM).
It elevates the work of incretin hormones, which are substantial for handling blood sugar count.
Vildagliptin is different from a lot of other antidiabetic solutions.
It has certain important benefits, such as a reduced risk of hypoglycemia, not affecting weight.
These things make it a good choice for those with diabetes, especially those who need more than one type of treatment.
There are strong quality standards in place when making vildagliptin as an API.
This makes sure that it is pure, stable, and follows the rules.
It meets the norms of IP, EP, and USP pharmacopoeias.
We keenly adhere to all the standards and rules.
Therapeutic Applications
Pharmacological Category: Antidiabetic agent
Type 2 Diabetes Mellitus (T2DM):
Specification Parameters
Packaging & Storage
Vildagliptin is packaged and stored with the help of protective materials to keep it safe and stable:
HDPE or fiber drums with two-layer polybags on the inside.
We offer personalised packaging solutions to fulfil the requirements of each buyer.
 It is advised to keep it in a cool, dry, and airy area.
Stay away from direct sunlight, humidity, and heat sources.
The preferred temperature range is between 2°C and 8°C.
When stored under recommended conditions, Vildagliptin remains stable for up to 36 months from the date of manufacture.